182 related articles for article (PubMed ID: 23630104)
1. Defects of leukocyte migration in primary immunodeficiencies.
Badolato R
Eur J Immunol; 2013 Jun; 43(6):1436-40. PubMed ID: 23630104
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte circulation: one-way or round-trip? Lessons from primary immunodeficiency patients.
Badolato R
J Leukoc Biol; 2004 Jul; 76(1):1-6. PubMed ID: 15075352
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte trafficking in primary immunodeficiencies.
Notarangelo LD; Badolato R
J Leukoc Biol; 2009 Mar; 85(3):335-43. PubMed ID: 19088178
[TBL] [Abstract][Full Text] [Related]
4. Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients.
Tassone L; Moratto D; Vermi W; De Francesco M; Notarangelo LD; Porta F; Lougaris V; Facchetti F; Plebani A; Badolato R
Blood; 2010 Dec; 116(23):4870-3. PubMed ID: 20736454
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
Dotta L; Tassone L; Badolato R
Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
[TBL] [Abstract][Full Text] [Related]
6. Leukocyte adhesion deficiency (LAD) II: a new adhesion defect due to absence of sialyl Lewis X, the ligand for selectins.
Etzioni A; Harlan JM; Pollack S; Phillips LM; Gershoni-Baruch R; Paulson JC
Immunodeficiency; 1993; 4(1-4):307-8. PubMed ID: 7513226
[No Abstract] [Full Text] [Related]
7. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
[TBL] [Abstract][Full Text] [Related]
8. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
McDermott DH; Murphy PM
Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
[TBL] [Abstract][Full Text] [Related]
9. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
[TBL] [Abstract][Full Text] [Related]
10. [CXCR4, a therapeutic target in rare immunodeficiencies?].
Bignon A; Biajoux V; Bouchet-Delbos L; Emilie D; Lortholary O; Balabanian K
Med Sci (Paris); 2011 Apr; 27(4):391-7. PubMed ID: 21524404
[TBL] [Abstract][Full Text] [Related]
11. Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome.
Badolato R; Dotta L; Tassone L; Amendola G; Porta F; Locatelli F; Notarangelo LD; Bertrand Y; Bachelerie F; Donadieu J
J Pediatr; 2012 Oct; 161(4):763-5. PubMed ID: 22748845
[TBL] [Abstract][Full Text] [Related]
12. Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.
Mc Guire PJ; Cunningham-Rundles C; Ochs H; Diaz GA
Clin Immunol; 2010 Jun; 135(3):412-21. PubMed ID: 20226738
[TBL] [Abstract][Full Text] [Related]
13. Warts and all: human papillomavirus in primary immunodeficiencies.
Leiding JW; Holland SM
J Allergy Clin Immunol; 2012 Nov; 130(5):1030-48. PubMed ID: 23036745
[TBL] [Abstract][Full Text] [Related]
14. Congenital defects in neutrophil dynamics.
Keszei M; Westerberg LS
J Immunol Res; 2014; 2014():303782. PubMed ID: 25165726
[TBL] [Abstract][Full Text] [Related]
15. [Clinical aspects, genetics and immunology of leukocyte adhesion protein deficiencies].
Uhlig T; Belohradsky BH
Ergeb Inn Med Kinderheilkd; 1993; 61():1-55. PubMed ID: 7900994
[No Abstract] [Full Text] [Related]
16. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
[TBL] [Abstract][Full Text] [Related]
17. Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.
Galli J; Pinelli L; Micheletti S; Palumbo G; Notarangelo LD; Lougaris V; Dotta L; Fazzi E; Badolato R
Orphanet J Rare Dis; 2019 Feb; 14(1):61. PubMed ID: 30819232
[TBL] [Abstract][Full Text] [Related]
18. Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome.
Gulino AV; Moratto D; Sozzani S; Cavadini P; Otero K; Tassone L; Imberti L; Pirovano S; Notarangelo LD; Soresina R; Mazzolari E; Nelson DL; Notarangelo LD; Badolato R
Blood; 2004 Jul; 104(2):444-52. PubMed ID: 15026312
[TBL] [Abstract][Full Text] [Related]
19. Primary immunodeficiencies caused by mutations in actin regulatory proteins.
Janssen E; Geha RS
Immunol Rev; 2019 Jan; 287(1):121-134. PubMed ID: 30565251
[TBL] [Abstract][Full Text] [Related]
20. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
